Search research articles
Contact Us
Filters
Showing results (291-300 of 807) with videos related to
Page
of 81
Sort By:
The Journal of Antimicrobial Chemotherapy
|
December 28, 2018
Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae
Shazad Mushtaq, Anna Vickers, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy
|
March 27, 2001
Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales
A P Johnson, M Warner, R C George, et al.
The Journal of Antimicrobial Chemotherapy
|
June 6, 2007
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
Shazad Mushtaq, Marina Warner, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy
|
October 10, 2008
Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06
David M Livermore, Russell Hope, Geraldine Brick, et al.
The Journal of Antimicrobial Chemotherapy
|
August 21, 2007
Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method
R Hope, T Parsons, S Mushtaq, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 28, 2014
Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia
Saber Yezli, Atef M Shibl, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy
|
November 5, 2020
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases
Shazad Mushtaq, Danièle Meunier, Anna Vickers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 7, 2020
Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its "Sell-By Date" in an Era of New Antibiotics and Regional Carbapenemase Epidemiology
David M Livermore, David P Nicolau, Katie L Hopkins, et al.
The New England Journal of Medicine
|
November 27, 1986
Randomized trial of allopurinol in the prevention of calcium oxalate calculi
B Ettinger, A Tang, J T Citron, et al.
The Journal of Antimicrobial Chemotherapy
|
August 16, 2022
Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales
Shazad Mushtaq, Paolo Garello, Anna Vickers, et al.
Page
of 81
Search research articles
Search
Showing results (291-300 of 807) with videos related to
Sort By:
Page
of 81
The Journal of Antimicrobial Chemotherapy
|
December 28, 2018
Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae
Shazad Mushtaq, Anna Vickers, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy
|
March 27, 2001
Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales
A P Johnson, M Warner, R C George, et al.
The Journal of Antimicrobial Chemotherapy
|
June 6, 2007
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
Shazad Mushtaq, Marina Warner, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy
|
October 10, 2008
Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06
David M Livermore, Russell Hope, Geraldine Brick, et al.
The Journal of Antimicrobial Chemotherapy
|
August 21, 2007
Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method
R Hope, T Parsons, S Mushtaq, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 28, 2014
Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia
Saber Yezli, Atef M Shibl, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy
|
November 5, 2020
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases
Shazad Mushtaq, Danièle Meunier, Anna Vickers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 7, 2020
Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its "Sell-By Date" in an Era of New Antibiotics and Regional Carbapenemase Epidemiology
David M Livermore, David P Nicolau, Katie L Hopkins, et al.
The New England Journal of Medicine
|
November 27, 1986
Randomized trial of allopurinol in the prevention of calcium oxalate calculi
B Ettinger, A Tang, J T Citron, et al.
The Journal of Antimicrobial Chemotherapy
|
August 16, 2022
Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales
Shazad Mushtaq, Paolo Garello, Anna Vickers, et al.
Page
of 81